Welcome

Please see below for the upcoming Dexcom clinical education webinars being presented at healthcare conferences around the globe.

Upcoming Webinars

9

June

The Emerging Role of the Use of Real-Time Continuous Glucose Monitoring in Type 2 Diabetes

11:00 AM PT/2:00 PM ET

A Dexcom presentation theater held in conjunction with AACE Annual Meeting 2021.

Speaker:	Dr. Viral Shah, MD, Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO
Moderator:	Cher Pastore, MS, RD, CDE, Manager, Clinical Education, Dexcom

14

July

Powered By: Explore the Capabilities of Dexcom G6 Integrated CGM (iCGM)

5:00 PM – 6:00 PM ET

A Dexcom presentation theater held in conjunction with ATDC Conference 2021.

Speakers:	Dr. Sushma Reddy, MD, Endocrinologist, Steady Health Dr. Greg Forlenza, MD, University of Colorado Hospital, Barbara Davis Center for Childhood Diabetes Kevin Sayer, Chairman, President & Chief Executive Officer, Dexcom
Moderator:	Cher Pastore, MS, RD, CDE, Manager, Clinical Education, Dexcom

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.